Adicet Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Adicet Bio
ACET Stock  USD 8.05  0.10  1.23%   
Analyzing historical trends in various income statement and balance sheet accounts from Adicet Bio's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adicet Bio's valuation are summarized below:
Gross Profit
25 M
Market Capitalization
77.3 M
Enterprise Value Revenue
2.1386
Earnings Share
(20.00)
Quarterly Revenue Growth
(1.00)
There are currently one hundred twenty fundamental signals for Adicet Bio that can be evaluated and compared over time across rivals. All traders should validate Adicet Bio's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 1.5 B in 2026. Enterprise Value is likely to drop to about 1.4 B in 2026

Adicet Bio Total Revenue

0.0

Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 3.4 K or Selling General Administrative of 34 M, as well as many indicators such as Price To Sales Ratio of 201, Dividend Yield of 1.0E-4 or PTB Ratio of 7.92. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
Build AI portfolio with Adicet Stock
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Adicet Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets213 M198.2 M266.5 M
Slightly volatile
Short and Long Term Debt Total14.7 M15.5 M64.1 M
Pretty Stable
Total Current Liabilities16.6 M17.5 M47.7 M
Slightly volatile
Property Plant And Equipment Net44.4 M42.3 M20.7 M
Slightly volatile
Current Deferred Revenue3.6 M5.5 M4.3 M
Slightly volatile
Accounts Payable4.1 M4.3 M20.4 M
Slightly volatile
Cash82.3 M65 M78.3 M
Slightly volatile
Non Current Assets Total56.6 M36.1 M73.9 M
Slightly volatile
Cash And Short Term Investments212.9 M202.7 M111.3 M
Slightly volatile
Common Stock Shares Outstanding106.1 M101 M38.9 M
Slightly volatile
Liabilities And Stockholders Equity213 M198.2 M266.5 M
Slightly volatile
Non Current Liabilities Total15.5 M16.4 M65.9 M
Pretty Stable
Other Current Assets3.3 M3.4 M10 M
Slightly volatile
Other Stockholder Equity826.5 M787.2 M287.7 M
Slightly volatile
Total Liabilities28.7 M30.2 M94.1 M
Slightly volatile
Total Current Assets156.4 M162.1 M192.6 M
Pretty Stable
Intangible Assets1.3 M1.4 M40.3 M
Slightly volatile
Common Stock6.8 K7.2 K117 K
Slightly volatile
Net Receivables371.9 K391.5 K61.3 M
Slightly volatile
Short Term Debt4.6 M2.8 M5.1 M
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Capital Lease Obligations16.3 M15.5 M20.6 M
Slightly volatile
Net Invested Capital233.7 M214.6 M153.4 M
Slightly volatile
Property Plant And Equipment Gross54.3 M66.8 M39.7 M
Slightly volatile
Capital Stock4.8 K9.2 K3.3 K
Slightly volatile
Non Current Liabilities Other99.2 K104.4 K674 K
Slightly volatile
Net Working Capital195.6 M184.9 M120.5 M
Slightly volatile

Adicet Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.6 M5.8 M4.7 M
Pretty Stable
Interest Expense3.4 K3.6 K1.3 M
Slightly volatile
Selling General Administrative34 M25.5 M40.8 M
Slightly volatile
Other Operating Expenses177.8 M114.9 M201.3 M
Slightly volatile
Research Development119.9 M114.2 M39.5 M
Slightly volatile
Cost Of Revenue5.5 M5.8 M155.9 M
Slightly volatile
Total Operating Expenses154.1 M146.8 M72.4 M
Slightly volatile
Selling And Marketing Expenses5.2 M5.5 M37.7 M
Slightly volatile
Interest Income12.9 M12.3 M3.4 M
Slightly volatile
Reconciled Depreciation3.9 M7.4 M2.4 M
Slightly volatile

Adicet Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation26.8 M25.6 M8.7 M
Slightly volatile
Begin Period Cash Flow192.9 M183.7 M88.2 M
Slightly volatile
Depreciation3.5 M5.8 M4.6 M
Pretty Stable
Capital Expenditures1.2 M1.3 M3.1 M
Pretty Stable
End Period Cash Flow83.5 M68.3 M79.7 M
Slightly volatile
Dividends Paid6.5 M8.1 M6.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio201212760
Very volatile
Dividend Yield1.0E-41.0E-41.0E-4
Slightly volatile
Days Sales Outstanding6.947.31117
Slightly volatile
Stock Based Compensation To Revenue0.50.620.3852
Slightly volatile
Capex To Depreciation0.150.161.7217
Pretty Stable
EV To Sales193203755
Very volatile
Inventory Turnover0.00.01.4997
Slightly volatile
Days Of Inventory On Hand68.1378.3285.1027
Slightly volatile
Payables Turnover0.160.172.5026
Slightly volatile
Sales General And Administrative To Revenue0.830.951.1877
Pretty Stable
Research And Ddevelopement To Revenue2.582.572.8311
Slightly volatile
Capex To Revenue0.630.60.3496
Slightly volatile
Cash Per Share2.781.813.6295
Slightly volatile
Days Payables Outstanding2.3 K2.2 K1.7 K
Slightly volatile
Income Quality0.680.710.9364
Pretty Stable
Intangibles To Total Assets0.05030.0530.6929
Pretty Stable
Current Ratio5.238.367.9533
Slightly volatile
Receivables Turnover54.2951.721.2495
Slightly volatile
Debt To Equity0.0790.08310.5849
Pretty Stable
Capex Per Share0.01090.01150.0871
Pretty Stable
Revenue Per Share0.660.78.5849
Slightly volatile
Interest Debt Per Share0.210.232.3484
Slightly volatile
Debt To Assets0.06690.07040.4828
Pretty Stable
Graham Number8.7114.9614.9872
Pretty Stable
Operating Cycle6.947.31143
Slightly volatile
Days Of Payables Outstanding2.3 K2.2 K1.7 K
Slightly volatile
Ebt Per Ebit1.121.061.0496
Pretty Stable
Long Term Debt To Capitalization0.02480.02610.1423
Slightly volatile
Total Debt To Capitalization0.09240.09720.1855
Slightly volatile
Debt Equity Ratio0.0790.08310.5849
Pretty Stable
Net Income Per E B T0.60.90.8481
Slightly volatile
Cash Ratio2.892.623.8909
Slightly volatile
Days Of Inventory Outstanding68.1378.3285.1027
Slightly volatile
Days Of Sales Outstanding6.947.31117
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.911.0129
Pretty Stable
Fixed Asset Turnover0.440.46864
Pretty Stable
Debt Ratio0.06690.07040.4828
Pretty Stable
Price Sales Ratio201212760
Very volatile
Asset Turnover0.08260.08691.1013
Slightly volatile
Gross Profit Margin0.940.890.7053
Slightly volatile

Adicet Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.6 B26.5 B
Slightly volatile
Enterprise Value1.4 B1.5 B26.5 B
Slightly volatile

Adicet Fundamental Market Drivers

Adicet Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Adicet Bio Financial Statements

Adicet Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M3.6 M
Cost Of Revenue5.8 M5.5 M
Stock Based Compensation To Revenue 0.62  0.50 
Sales General And Administrative To Revenue 0.95  0.83 
Research And Ddevelopement To Revenue 2.57  2.58 
Capex To Revenue 0.60  0.63 
Revenue Per Share 0.70  0.66 
Ebit Per Revenue(3.34)(3.51)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY